{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:56:28Z","timestamp":1778860588285,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473100"],"award-info":[{"award-number":["81473100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["2013011060-2"],"award-info":[{"award-number":["2013011060-2"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09101003-001-017"],"award-info":[{"award-number":["2017ZX09101003-001-017"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.intimp.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T23:59:45Z","timestamp":1531612785000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Therapeutic effects of 5,2\u2032-dibromo-2,4\u2032,5\u2032-trihydroxydiphenylmethanone (LM49) in an experimental rat model of acute pyelonephritis by immunomodulation and anti-inflammation"],"prefix":"10.1016","volume":"62","author":[{"given":"Yuan Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu E.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong Rong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao Guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu Liang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1A","key":"10.1016\/j.intimp.2018.07.001_bb0005","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2018.07.001_bb0010","first-page":"114","article-title":"Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia Pacific region","volume":"63","author":"Hsueh","year":"2011","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.intimp.2018.07.001_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0924-8579(01)00303-X","article-title":"Urinary tract infection in adults: research priorities and strategies","volume":"17","author":"Ronald","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2018.07.001_bb0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.07.001_bb0025","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.intimp.2018.07.001_bb0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrurol.2015.199","article-title":"The emerging threat of multidrug-resistant gram-negative bacteria in urology","volume":"12","author":"Zowawi","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/519268","article-title":"Population-based epidemiologic analysis of acute pyelonephritis","volume":"45","author":"Czaja","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.07.001_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/46.2.223","article-title":"Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands","volume":"46","author":"Goettsch","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.intimp.2018.07.001_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.162.1.41","article-title":"National patterns in the treatment of urinary tract infections in women by ambulatory care physicians","volume":"162","author":"Huang","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2018.07.001_bb0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2006.02.009","article-title":"Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)","volume":"27","author":"Zhanel","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.intimp.2018.07.001_bb0060","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.mcna.2013.03.006","article-title":"Management of urinary tract infections in the era of increasing antimicrobial resistance","volume":"97","author":"Shepherd","year":"2013","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.intimp.2018.07.001_bb0065","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1172\/JCI115644","article-title":"Local cytokine production in a murine model of Escherichia coli pyelonephritis","volume":"89","author":"Rugo","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.07.001_bb0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-079X.2006.00357.x","article-title":"Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats","volume":"41","author":"Sener","year":"2006","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.intimp.2018.07.001_bb0075","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/iai.57.7.2196-2202.1989","article-title":"Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring","volume":"57","author":"Meylan","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2018.07.001_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4137\/JEN.S25096","article-title":"Isolation and identification of a flavones apigenin from marine red alga Acanthophora spicifera with antinociceptive and anti-inflammatory activities","volume":"10","author":"El Shoubaky","year":"2016","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.intimp.2018.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/md9071273","article-title":"Bromophenols in marine algae and their bioactivities","volume":"9","author":"Liu","year":"2011","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2018.07.001_bb0090","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/md11082769","article-title":"Cellular antioxidant effect of four bromophenols from the red algae, Vertebrata lanosa","volume":"11","author":"Olsen","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2018.07.001_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bioorg.2015.04.006","article-title":"Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives","volume":"60","author":"\u00d6zta\u015fk\u0131n","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.intimp.2018.07.001_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1573406411309020013","article-title":"Synthesis and biological activities of new halophenols","volume":"9","author":"Zheng","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.intimp.2018.07.001_bb0105","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.bmcl.2010.05.068","article-title":"Synthesis and biological activity of halophenols as potent antioxidant and cytoprotective agents","volume":"20","author":"Zhao","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2018.07.001_bb0110","series-title":"The Application of Two Bromophenols and Their Medicinal Salts as the Drugs Against the Myocardial Ischemia Reperfusion Injury","author":"Li","year":"2013"},{"key":"10.1016\/j.intimp.2018.07.001_bb0115","series-title":"The Application of Polyhydroxyl Bromo-diphenylketone Compounds and Their Derivatives in the Treatment and Prevention of Atherosclerosis","author":"Li","year":"2014"},{"key":"10.1016\/j.intimp.2018.07.001_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0147-9571(03)00011-0","article-title":"Prevention of tissue injury in an ascending mouse model of chronic pyelonephritis\u2014role of free radical scavengers","volume":"27","author":"Gupta","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.07.001_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00041552-199703000-00001","article-title":"Glomerulonephritis: roles for lipoxygenase pathways in pathophysiology and therapy","volume":"6","author":"Badr","year":"1997","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.intimp.2018.07.001_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1574-695X.1996.tb00213.x","article-title":"Oxygen-dependent and -independent mechanisms of renal injury in experimental ascending pyelonephritis","volume":"13","author":"Gupta","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0135","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/iai.59.11.4168-4172.1991","article-title":"Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring","volume":"59","author":"Mundi","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2018.07.001_bb0140","series-title":"Performance Standards for Antimicrobial Susceptibility Testing, Fifteenth Informational Supplement M100-S15","author":"Clinical and Laboratory Standards Institute","year":"2005"},{"key":"10.1016\/j.intimp.2018.07.001_bb0145","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AAC.04548-14","article-title":"In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods","volume":"59","author":"Heine","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2018.07.001_bb0150","first-page":"858","article-title":"The testing errors of broth microdilution methods for the antimicrobial susceptibility testing","volume":"41","author":"Zhang","year":"2016","journal-title":"Chin. J. Antibiot."},{"key":"10.1016\/j.intimp.2018.07.001_bb0155","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/314700","article-title":"Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis","volume":"179","author":"Kabor\u00e9","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.07.001_bb0160","first-page":"30","article-title":"Establishment and observation of rats model with acute pyelonephritis","volume":"14","author":"Zhou","year":"2017","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.intimp.2018.07.001_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2003.02076.x","article-title":"Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1\u03b2-deficient mice","volume":"131","author":"Hertting","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0170","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/aje\/kwh308","article-title":"The epidemiology of acute pyelonephritis in South Korea, 1997\u20131999","volume":"160","author":"Ki","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0175","first-page":"283","article-title":"Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection","volume":"35","author":"Elhanan","year":"1997","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.intimp.2018.07.001_bb0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0185","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12879-015-1123-5","article-title":"Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis","volume":"15","author":"Raman","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.intimp.2018.07.001_bb0190","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","article-title":"Multidrug resistance, inappropriate initial antibiotic therapy and mortality in gramnegative severe sepsis and septic shock: a retrospective cohort study","volume":"18","author":"Zilberberg","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2018.07.001_bb0195","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1159\/000075570","article-title":"Cytokines and cell adhesion molecules in the inflammatory response during acute pyelonephritis","volume":"96","author":"Webb","year":"2004","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0200","first-page":"265","article-title":"Mechanisms of renal damage in chronic pyelonephritis (reflux nephropathy)","author":"Roberts","year":"1995","journal-title":"Curr. Top. Pathol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7028478","article-title":"Heme oxygenase-1, a key enzyme for the cytoprotective actions of halophenols by upregulating Nrf2 expression via activating Erk1\/2 and PI3K\/Akt in EA.hy926 cells","volume":"2017","author":"Feng","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2018.07.001_bb0210","first-page":"111","article-title":"Novel biomarkers for the diagnosis of urinary tract infection-a systematic review","volume":"5","author":"Nanda","year":"2009","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.intimp.2018.07.001_bb0215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/314534","article-title":"Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection","volume":"179","author":"Otto","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.07.001_bb0220","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1590\/S1677-5538.IBJU.2016.0049","article-title":"The combination of urinary IL-6 and renal biometry as useful diagnostic tools to differentiate acute pyelonephritis from lower urinary tract infection","volume":"42","author":"Azab","year":"2016","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.intimp.2018.07.001_bb0225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1440-1797.2007.00819.x","article-title":"Urine interleukin-1beta in children with acute pyelonephritis and renal scarring","volume":"12","author":"Sheu","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.intimp.2018.07.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/aa6545","article-title":"Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers","volume":"11","author":"Peters","year":"2017","journal-title":"J. Breath Res."},{"key":"10.1016\/j.intimp.2018.07.001_bb0235","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s10753-016-0441-0","article-title":"Activated CD4+ and CD8+ T Cell Proportions in multiple sclerosis patients","volume":"39","author":"Arneth","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2018.07.001_bb0240","doi-asserted-by":"crossref","first-page":"393217","DOI":"10.1155\/2014\/393217","article-title":"Hesperidin inhibits inflammatory response induced by Aeromonas hydrophila infection and alters CD4+\/CD8+ T cell ratio","volume":"2014","author":"Abuelsaad","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2018.07.001_bb0245","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918303023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918303023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:11:34Z","timestamp":1761585094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918303023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":49,"alternative-id":["S1567576918303023"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.07.001","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of 5,2\u2032-dibromo-2,4\u2032,5\u2032-trihydroxydiphenylmethanone (LM49) in an experimental rat model of acute pyelonephritis by immunomodulation and anti-inflammation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}